Daniel B Zoccal1. 1. Department of Physiology and Pathology, School of Dentistry of Araraquara, São Paulo State University (UNESP), Araraquara, SP, Brazil.
Abstract
NEW FINDINGS: What is the topic of this review? Chronic intermittent hypoxia (CIH), as observed in patients with obstructive sleep apnoea, is associated with the development of sympathetically mediated arterial hypertension. Nevertheless, the mechanisms underpinning the augmented sympathetic outflow in CIH still remain under investigation. What advances does it highlight? In this report, I present experimental evidence supporting the hypothesis that changes in the function of the respiratory network and coupling with the sympathetic nervous system may be considered as a novel and relevant mechanism for the increase in baseline sympathetic outflow in animals submitted to CIH. Chronic intermittent hypoxia (CIH) has been identified as a relevant risk factor for the development of enhanced sympathetic outflow and arterial hypertension. Several studies have highlighted the importance of peripheral chemoreceptors for the cardiovascular changes elicited by CIH. However, the effects of CIH on the central mechanisms regulating sympathetic outflow are not fully elucidated. Our research group has explored the hypothesis that the enhanced sympathetic drive following CIH exposure is, at least in part, dependent on alterations in the respiratory network and its interaction with the sympathetic nervous system. In this report, I discuss the changes in the discharge profile of baseline sympathetic activity in rats exposed to CIH, their association with the generation of active expiration and the interactions between expiratory and sympathetic neurones after CIH conditioning. Together, these findings are consistent with the theory that mechanisms of central respiratory-sympathetic coupling are a novel factor in the development of neurogenic hypertension.
NEW FINDINGS: What is the topic of this review? Chronic intermittent hypoxia (CIH), as observed in patients with obstructive sleep apnoea, is associated with the development of sympathetically mediated arterial hypertension. Nevertheless, the mechanisms underpinning the augmented sympathetic outflow in CIH still remain under investigation. What advances does it highlight? In this report, I present experimental evidence supporting the hypothesis that changes in the function of the respiratory network and coupling with the sympathetic nervous system may be considered as a novel and relevant mechanism for the increase in baseline sympathetic outflow in animals submitted to CIH. Chronic intermittent hypoxia (CIH) has been identified as a relevant risk factor for the development of enhanced sympathetic outflow and arterial hypertension. Several studies have highlighted the importance of peripheral chemoreceptors for the cardiovascular changes elicited by CIH. However, the effects of CIH on the central mechanisms regulating sympathetic outflow are not fully elucidated. Our research group has explored the hypothesis that the enhanced sympathetic drive following CIH exposure is, at least in part, dependent on alterations in the respiratory network and its interaction with the sympathetic nervous system. In this report, I discuss the changes in the discharge profile of baseline sympathetic activity in rats exposed to CIH, their association with the generation of active expiration and the interactions between expiratory and sympathetic neurones after CIH conditioning. Together, these findings are consistent with the theory that mechanisms of central respiratory-sympathetic coupling are a novel factor in the development of neurogenic hypertension.
Authors: Davi J A Moraes; Mirela B Dias; Roberta Cavalcanti-Kwiatkoski; Benedito H Machado; Daniel B Zoccal Journal: J Neurophysiol Date: 2012-05-16 Impact factor: 2.714
Authors: Davi J A Moraes; Melina P da Silva; Leni G H Bonagamba; André S Mecawi; Daniel B Zoccal; José Antunes-Rodrigues; Wamberto A Varanda; Benedito H Machado Journal: J Neurosci Date: 2013-12-04 Impact factor: 6.167
Authors: Rodrigo P Pedrosa; Luciano F Drager; Carolina C Gonzaga; Marcio G Sousa; Lílian K G de Paula; Aline C S Amaro; Celso Amodeo; Luiz A Bortolotto; Eduardo M Krieger; T Douglas Bradley; Geraldo Lorenzi-Filho Journal: Hypertension Date: 2011-10-03 Impact factor: 10.190
Authors: Daniel B Zoccal; Annabel E Simms; Leni G H Bonagamba; Valdir A Braga; Anthony E Pickering; Julian F R Paton; Benedito H Machado Journal: J Physiol Date: 2008-05-01 Impact factor: 5.182
Authors: Yaroslav I Molkov; Daniel B Zoccal; Davi J A Moraes; Julian F R Paton; Benedito H Machado; Ilya A Rybak Journal: J Neurophysiol Date: 2011-04-06 Impact factor: 2.714
Authors: William H Barnett; Ana P Abdala; Julian F R Paton; Ilya A Rybak; Daniel B Zoccal; Yaroslav I Molkov Journal: Exp Neurol Date: 2016-05-27 Impact factor: 5.330
Authors: Julian M Stewart; Paul Pianosi; Mohamed A Shaban; Courtney Terilli; Maria Svistunova; Paul Visintainer; Marvin S Medow Journal: J Appl Physiol (1985) Date: 2018-08-23
Authors: Patrice G Guyenet; Ruth L Stornetta; Benjamin B Holloway; George M P R Souza; Stephen B G Abbott Journal: Hypertension Date: 2018-09 Impact factor: 10.190
Authors: Dmitriy Yu Uryumtsev; Valentina V Gultyaeva; Margarita I Zinchenko; Victor I Baranov; Vladimir N Melnikov; Natalia V Balioz; Sergey G Krivoschekov Journal: Front Physiol Date: 2020-06-30 Impact factor: 4.566